Calumet Specialty Products Partners
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance Brands segments. The Specialty Products and Solutions segment offers various solvents, waxes, custo… Read more
Calumet Specialty Products Partners (CLMT) - Net Assets
Latest net assets as of September 2025: $-449.70 Million USD
Based on the latest financial reports, Calumet Specialty Products Partners (CLMT) has net assets worth $-449.70 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.73 Billion) and total liabilities ($3.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-449.70 Million |
| % of Total Assets | -16.45% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -177.21% |
| Growth Volatility | 280.87 |
Calumet Specialty Products Partners - Net Assets Trend (2001–2024)
This chart illustrates how Calumet Specialty Products Partners's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Calumet Specialty Products Partners (2001–2024)
The table below shows the annual net assets of Calumet Specialty Products Partners from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-466.30 Million | -90.56% |
| 2023-12-31 | $-244.70 Million | +14.95% |
| 2022-12-31 | $-287.70 Million | +25.29% |
| 2021-12-31 | $-385.10 Million | -199.46% |
| 2020-12-31 | $-128.60 Million | -695.37% |
| 2019-12-31 | $21.60 Million | -67.12% |
| 2018-12-31 | $65.70 Million | -45.20% |
| 2017-12-31 | $119.90 Million | -45.18% |
| 2016-12-31 | $218.70 Million | -63.79% |
| 2015-12-31 | $603.90 Million | -25.46% |
| 2014-12-31 | $810.20 Million | -23.77% |
| 2013-12-31 | $1.06 Billion | +19.44% |
| 2012-12-31 | $889.79 Million | +22.07% |
| 2011-12-31 | $728.90 Million | +83.01% |
| 2010-12-31 | $398.28 Million | -17.94% |
| 2009-12-31 | $485.35 Million | +2.56% |
| 2008-12-31 | $473.21 Million | +18.41% |
| 2007-12-31 | $399.64 Million | +5.53% |
| 2006-12-31 | $378.69 Million | +869.64% |
| 2005-12-31 | $39.05 Million | +13.15% |
| 2004-12-31 | $34.51 Million | -- |
| 2003-12-31 | $0.00 | -- |
| 2002-12-31 | $0.00 | -- |
| 2001-12-31 | $0.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Calumet Specialty Products Partners's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 153900000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $900.00K | % |
| Other Comprehensive Income | $800.00K | % |
| Other Components | $824.50 Million | % |
| Total Equity | $-712.80 Million | 100.00% |
Calumet Specialty Products Partners Competitors by Market Cap
The table below lists competitors of Calumet Specialty Products Partners ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HEXPOL AB ser. B
LSE:0R7O
|
$1.63 Billion |
|
Linktel Technologies Co. Ltd. A
SHE:301205
|
$1.63 Billion |
|
HUTCHMED (China) Limited
PINK:HMDCF
|
$1.63 Billion |
|
Quaker Chemical Corporation
NYSE:KWR
|
$1.63 Billion |
|
Manappuram Finance Limited
NSE:MANAPPURAM
|
$1.63 Billion |
|
Hunan Zhongke Electric
SHE:300035
|
$1.63 Billion |
|
Mednax Inc
NYSE:MD
|
$1.63 Billion |
|
Turning Point Brands Inc
NYSE:TPB
|
$1.63 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Calumet Specialty Products Partners's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -491,600,000 to -712,800,000, a change of -221,200,000.
- Net loss of 222,000,000 reduced equity.
- Other comprehensive income increased equity by 8,000,000.
- Other factors decreased equity by 7,200,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-222.00 Million | -31.14% |
| Other Comprehensive Income | $8.00 Million | +1.12% |
| Other Changes | $-7.20 Million | -1.01% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Calumet Specialty Products Partners's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $17362.00 | $28.63 | x |
| 2003-12-31 | $25544.00 | $28.63 | x |
| 2004-12-31 | $1.37 | $28.63 | x |
| 2005-12-31 | $1.55 | $28.63 | x |
| 2006-12-31 | $13.17 | $28.63 | x |
| 2007-12-31 | $13.90 | $28.63 | x |
| 2008-12-31 | $14.68 | $28.63 | x |
| 2009-12-31 | $14.99 | $28.63 | x |
| 2010-12-31 | $11.27 | $28.63 | x |
| 2011-12-31 | $17.09 | $28.63 | x |
| 2012-12-31 | $15.98 | $28.63 | x |
| 2013-12-31 | $15.64 | $28.63 | x |
| 2014-12-31 | $11.63 | $28.63 | x |
| 2015-12-31 | $8.06 | $28.63 | x |
| 2016-12-31 | $2.84 | $28.63 | x |
| 2017-12-31 | $1.55 | $28.63 | x |
| 2018-12-31 | $-0.11 | $28.63 | x |
| 2019-12-31 | $0.12 | $28.63 | x |
| 2020-12-31 | $-1.76 | $28.63 | x |
| 2021-12-31 | $-4.92 | $28.63 | x |
| 2022-12-31 | $-6.73 | $28.63 | x |
| 2023-12-31 | $-6.14 | $28.63 | x |
| 2024-12-31 | $-8.57 | $28.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Calumet Specialty Products Partners utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.30%
- • Asset Turnover: 1.52x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-28.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -76.51% | -4.33% | 1.76x | 10.07x | $-15.02 Million |
| 2003 | -19.30% | -1.15% | 2.27x | 7.42x | $-7.49 Million |
| 2004 | 25.99% | 1.66% | 1.70x | 9.22x | $5.52 Million |
| 2005 | 29.01% | 0.88% | 3.22x | 10.23x | $7.42 Million |
| 2006 | 24.79% | 5.72% | 3.10x | 1.40x | $56.01 Million |
| 2007 | 20.74% | 5.06% | 2.41x | 1.70x | $42.91 Million |
| 2008 | 9.39% | 1.79% | 2.30x | 2.28x | $-2.88 Million |
| 2009 | 12.48% | 3.28% | 1.79x | 2.13x | $12.01 Million |
| 2010 | 4.11% | 0.75% | 2.15x | 2.55x | $-23.46 Million |
| 2011 | 11.81% | 2.75% | 1.81x | 2.38x | $13.18 Million |
| 2012 | 22.99% | 4.39% | 2.07x | 2.53x | $115.56 Million |
| 2013 | 0.31% | 0.06% | 2.02x | 2.53x | $-102.98 Million |
| 2014 | -13.85% | -1.94% | 1.86x | 3.85x | $-193.22 Million |
| 2015 | -23.08% | -3.31% | 1.43x | 4.88x | $-199.79 Million |
| 2016 | -150.25% | -9.13% | 1.32x | 12.46x | $-350.47 Million |
| 2017 | -86.57% | -2.76% | 1.40x | 22.43x | $-115.79 Million |
| 2018 | 0.00% | -1.58% | 1.68x | 0.00x | $-54.23 Million |
| 2019 | -454.17% | -1.26% | 1.86x | 193.52x | $-44.56 Million |
| 2020 | 0.00% | -6.57% | 1.25x | 0.00x | $-135.24 Million |
| 2021 | 0.00% | -8.10% | 1.48x | 0.00x | $-216.01 Million |
| 2022 | 0.00% | -3.62% | 1.71x | 0.00x | $-116.44 Million |
| 2023 | 0.00% | 1.15% | 1.52x | 0.00x | $97.26 Million |
| 2024 | 0.00% | -5.30% | 1.52x | 0.00x | $-150.72 Million |
Industry Comparison
This section compares Calumet Specialty Products Partners's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $7,181,833,981
- Average return on equity (ROE) among peers: 7.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Calumet Specialty Products Partners (CLMT) | $-449.70 Million | -76.51% | N/A | $1.63 Billion |
| AirBoss of America Corp (ABSSF) | $197.00 Million | -16.19% | 1.24x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $19.13 Million | 17.11% | 0.33x | $0.98 |
| Aimia Inc (AIMFF) | $1.29 Billion | -4.63% | 2.83x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $11.83 Billion | 14.08% | 1.26x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $7.58 Billion | 14.03% | 1.29x | $9.73 Billion |
| Albemarle Corp (ALB) | $545.00 Million | 9.41% | 1.09x | $19.53 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $49.59 Billion | 15.64% | 1.50x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $97.54 Million | -5.87% | 0.01x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $333.00 Million | 14.14% | 0.12x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $345.21 Million | 13.35% | 0.40x | $212.84 Million |